Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.

Retter MW, Johnson JC, Peckham DW, Bannink JE, Bangur CS, Dresser K, Cai F, Foy TM, Fanger NA, Fanger GR, Woda B, Rock KL.

Cancer Res. 2005 Jul 15;65(14):6425-34.

2.

Uptake of antigen-antibody complexes by human dendritic cells.

Fanger NA, Guyre PM, Graziano RF.

Methods Mol Med. 2001;64:377-86. doi: 10.1385/1-59259-150-7:377.

PMID:
21374276
3.

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Fanger NA, Maliszewski CR, Schooley K, Griffith TS.

J Exp Med. 1999 Oct 18;190(8):1155-64.

4.

The leukocyte immunoglobulin-like receptors (LIRs): a new family of immune regulators.

Fanger NA, Borges L, Cosman D.

J Leukoc Biol. 1999 Aug;66(2):231-6. Review.

PMID:
10449159
5.

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA.

J Exp Med. 1999 Apr 19;189(8):1343-54.

6.

Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues.

Murphy M, Walter BN, Pike-Nobile L, Fanger NA, Guyre PM, Browning JL, Ware CF, Epstein LB.

Cell Death Differ. 1998 Jun;5(6):497-505.

7.

The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes.

Fanger NA, Cosman D, Peterson L, Braddy SC, Maliszewski CR, Borges L.

Eur J Immunol. 1998 Nov;28(11):3423-34.

8.

Expanding dendritic cells in vivo enhances the induction of oral tolerance.

Viney JL, Mowat AM, O'Malley JM, Williamson E, Fanger NA.

J Immunol. 1998 Jun 15;160(12):5815-25.

9.

Activation of human T cells by major histocompatability complex class II expressing neutrophils: proliferation in the presence of superantigen, but not tetanus toxoid.

Fanger NA, Liu C, Guyre PM, Wardwell K, O'Neil J, Guo TL, Christian TP, Mudzinski SP, Gosselin EJ.

Blood. 1997 Jun 1;89(11):4128-35.

10.

Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells.

Fanger NA, Voigtlaender D, Liu C, Swink S, Wardwell K, Fisher J, Graziano RF, Pfefferkorn LC, Guyre PM.

J Immunol. 1997 Apr 1;158(7):3090-8.

PMID:
9120261
11.

Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells.

Fanger NA, Wardwell K, Shen L, Tedder TF, Guyre PM.

J Immunol. 1996 Jul 15;157(2):541-8.

PMID:
8752900
12.

Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.

Heijnen IA, van Vugt MJ, Fanger NA, Graziano RF, de Wit TP, Hofhuis FM, Guyre PM, Capel PJ, Verbeek JS, van de Winkel JG.

J Clin Invest. 1996 Jan 15;97(2):331-8.

Supplemental Content

Loading ...
Support Center